Alerts for Metadate ER

Title Date Published Source
MHRA Review of METHYLPHENIDATE and Risk of Genetic Damage and Update to Patient Information Leaflet 2010-Feb-15 MHRA
Ongoing FDA Safety Review of Stimulant Mediations Used to Treat ADHD in Children 2009-Jun-16 FDA
Several lots of DAYTRANA (methylphenidate transdermal system) Voluntarily Recalled 2009-Mar-20 Manufacturer
Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings 2009-Mar-09 FDA
Several lots of DAYTRANA (methylphenidate transdermal system) voluntarily recalled 2008-Aug-26 Manufacturer

See alerts for all drugs

DISCLAIMER: iGuard is not intended to be a substitute for professional medical advice. iGuard cannot and does not take into consideration every possible interaction or account for individual responses to medicine. Different individuals may respond to medication in different ways. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Always seek the advice of a qualified health provider with any questions you may have before making any changes to your treatment. The use of the iGuard site and its content is at your own risk. The iGuard site and the information contained in it is intended for users in the United States and information in other countries may be different.

HACKER SAFE certified sites prevent over 99.9% of hacker crime.
Bookmark and Share